{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_caplacizumab",
          "name": "Caplacizumab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_anticoagulants",
          "name": "Anticoagulants"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_dialysis",
          "name": "Dialysis"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_supportive_care",
          "name": "Supportive care"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_fibrinogen_concentrate",
          "name": "Fibrinogen concentrate"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_caplacizumab",
          "type": "Drug",
          "label": "Caplacizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dialysis",
          "type": "Drug",
          "label": "Dialysis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_supportive_care",
          "type": "Drug",
          "label": "Supportive care",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fibrinogen_concentrate",
          "type": "Drug",
          "label": "Fibrinogen concentrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_a_typical_haemolytic_uraemic_syndrome",
          "type": "Disease",
          "label": "Atypical haemolytic uraemic syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知用于治疗该病症"
        },
        {
          "source": "drug_ravulizumab",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "可作为Eculizumab的替代药物"
        },
        {
          "source": "drug_corticosteroids",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "常用于减轻炎症反应"
        },
        {
          "source": "drug_caplacizumab",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于与血栓有关的病症"
        },
        {
          "source": "drug_anticoagulants",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "在某些情况减少凝血相关风险"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "用于去除血液中的有害成分"
        },
        {
          "source": "drug_dialysis",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于肾功能不全的支持"
        },
        {
          "source": "drug_supportive_care",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "作为基础护理支持"
        },
        {
          "source": "drug_fibrinogen_concentrate",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "在凝血相关治疗中的应用"
        },
        {
          "source": "drug_rituximab",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能在免疫调节中发挥作用"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "用于抑制免疫反应"
        },
        {
          "source": "drug_cyclosporine",
          "target": "disease_a_typical_haemolytic_uraemic_syndrome",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "免疫抑制用于各种自身免疫疾病"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物可能对 Atypical haemolytic uraemic syndrome 有效",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "所有药物在理论上适用于该疾病的治疗（基于已有文献及临床使用情况）"
    ],
    "uncertainties": [
      "具体疗效尚需通过临床试验证实"
    ],
    "next_focus_for_pi": [
      "是否需要进一步探索个别药物的作用机制与临床数据"
    ]
  }
}